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Abstract 
The conversion of 3,-glutamylcysteinylethyl ster (~/-GCE) to glutathione in a reduced form (GSH) was examined using isolated rat 
hepatocytes pretreated with dtiethyimaleate, a GSH-depletor. Incubation of hepatocytes with 0.1 and 5.0 mM ~/-GCE (~/-GCE-hepato- 
cytes) over a 30-min period resulted in time-dependent i creases in intracellular GSH and nonprotein-SH (NP-SH) concentrations. 
Hepatocytes incubated with 5.0 mM but not 0.1 mM GSH over a period of 30 min showed atime-dependent increase in intracellular GSH 
concentration. I  the ~/-GCE-hepatocytes pretreated with bis-(p-nitrophenyl)phosphate (BNPP), a non-specific esterase inhibitor, an 
enhancement of intracellular GSH concentration was markedly reduced. "y-GCE concentration i  the ~-GCE-hepatocytes with BNPP 
pretreatment was significantly higher than that in the cells without BNPP pretreatment, although there was no difference in the total 
amount of intracellular NP-SH, i.e., ~-GCE, GSH, ~/-glutamylcysteine, cysteine thyl ester, and cysteine between both ~/-GCE-hepato- 
cytes. The present results indicate that ~/-GCE is transported into liver cells more easily than GSH itself, resulting in its conversion to 
GSH via esterase and glutathione synthetase within the cells. 
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1. Introduction 
Glutathione is a tripepdde composed of glutamic acid 
(Glu), cysteine (Cys), and glycine (Gly), i.e., ~/-glutamyl- 
cysteinylglycine and exits in many tissues. The liver is 
among tissues with the hitghest content of glutathione and 
the main tissue participal~ing in glutathione synthesis [1]. 
Glutathione is synthesized in two steps catalyzed by ~/- 
glutamylcysteine synthetase (first step) and glutathione 
synthetase (second step), and the first step is known to be 
rate limiting for cellular glutathione synthesis [1]. A re- 
duced form of glutathione (GSH) present in liver cells has 
Abbreviations: BNPP, bis-(p-nitrophenyl)phosphate; Cys, cysteine; 
CysOEt, L-cysteine thyl ester; DEM, diethylmaleate; DTNB, 5,5'-di- 
thiobis(2-nitrobenzoic acid); ~-GC, "/-glutamylcysteine; ~/-GCE, ~/- 
glutamylcysteinylethyl ester; GSH, reduced glutathione; HBSS, Hanks" 
balanced salt solution; LDH, lactate dehydrogenase; MB, monobromobi- 
mane; NP-SH, nonprotein-SH. 
* Corresponding author. Fax: + 81 562 931193. 
been demonstrated to possess a variety of physiological 
functions, including protection of the cells against oxida- 
tive damage and detoxification of xenobiotics via chemical 
and enzymatic reactions [2]. 
Depletion of liver GSH often occurs in humans and 
experimental nimals with liver injuries [3,4]. However, 
exogenous GSH is unable to cross liver cell membranes as 
the intact tripeptide under physiological conditions [5,6]. 
Several studies using liposomal GSH [7], N-acetylcysteine 
[8], L-2-oxothiazolidine-4-carboxylate [9], and glutathione 
ester [10] have shown that increasing intracellular GSH 
levels leads to protection of damaged livers. We synthe- 
sized ~/-glutamylcysteinylethyl ester (~/-GCE) because the 
SH-compound was expected to be able to become a pre- 
cursor of ~/-glutamylcysteine (~/-GC), a substrate for glu- 
tathione synthetase, after its hydrolysis via esterase in 
tissues [11]. In addition, it has been demonstrated that 
when ~/-GCE is subcutaneously injected to new-born mice 
four times daily at 2.5-h intervals, a marked increase in 
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GSH levels occurs in the liver as well as the kidney and 
the eye [12]. It has been reported that ",/-GCE can protect 
ischemia/reperfusion-induced liv r injury with a decrease 
in hepatic GSH levels in rats possibly by maintaining 
hepatic GSH levels and that this protective ffect due to 
~-GCE is much greater than that due to GSH [13,14]. It 
has also been reported that ",/-GCE prevents immuno- 
logical cell injury with a decrease in intracellular GSH 
levels in isolated rat hepatocytes with anti-rat liver plasma 
membrane antiserum treatment possibly by maintaining the 
integrity of the plasma membrane through its conversion to 
GSH within the cells and that ~/-GCE prevents this cell 
injury more strongly than GSH [15]. Although it has thus 
been demonstrated that ~/-GCE enhances liver GSH levels 
under physiological conditions and that this SH-compound 
maintains liver GSH levels under pathophysiological on- 
ditions, however, it is still unclear how 3,-GCE is trans- 
ported into liver cells and how the SH-compound trans- 
ported into liver cells is converted to GSH within the cells. 
Therefore, as a first step of investigation on the mecha- 
nism for an enhancement of hepatocellular GSH levels by 
~/-GCE treatment, we examined the conversion of -,/-GCE 
to GSH using isolated rat hepatocytes pretreated with 
diethylmaleate (DEM), a GSH-depletor. 
Hanks' balanced salt solution (HBSS) (pH 7.2) with 1.0 
mM DEM at 37°C for 10 min. After incubation, the 
hepatocytes were washed with fresh HBSS twice. These 
GSH-depleted hepatocytes were used throughout this study. 
GSH was determined by the enzymatic recycling method 
using glutathione reductase and DTNB as described by 
Tietze [17] and Griffith [18]. Cell damage in DEM-treated 
hepatocytes was estimated by checking release of lactate 
dehydrogenase (LDH) from the hepatocytes into the incu- 
bation medium. LDH was assayed by the method of 
Babson and Phillips [19]. 
2.4. Measurement of GSH synthetic activity in hepatocytes 
GSH synthetic activity in hepatocytes was measured as 
follows: GSH in hepatocytes was measured before and 
after incubation in HBSS containing Glu (1.0 mM), Gly 
(1.0 mM), Met (1.0 mM), and Ser (1.0 mM) at 37°C for 30 
rain. The activity in hepatocytes was estimated from the 
increase of intracellular GSH concentration by the incuba- 
tion. GSH was measured by the above-described nzy- 
matic recycling method. 
2.5. Estimation of GSH uptake into hepatocytes 
2. Materials and methods 
2.1. Animals 
Male Wistar rats aged 6 wk (150-180 g) were used in 
this study. The animals were obtained from Shizuoka 
Laboratory Animal Center Co. (Hamamatsu, Japan) and 
fed a rat chow, Oriental MF (Oriental Yeast Co., Tokyo, 
Japan) with free access to water for at least 1 wk before 
use. 
2.2. Chemicals 
Bis-(p-nitrophenyl)phosphate (BNPP) and L-cysteine 
ethyl ester (CysOEt) were purchased from Sigma Chemi- 
cal Co. (St. Louis, MO, USA); ~/-GC from Kohjin Co. 
(Tokyo, Japan); monobromobimane (MB) from Cal- 
biochem Co. (La Jolla, CA, USA). GSH, DEM, 5,5'-di- 
thiobis(2-nitrobenzoic acid) (DTNB), L-GIy, L-GIu, L-serine 
(Ser), L-methionine (Met), and other reagents were ob- 
tained from Wako Pure Chemical Ind. (Osaka, Japan). 
~-GCE was prepared as described previously [11,12]. 
2.3. Preparation of GSH-depleted hepatocytes 
Isolated rat hepatocytes were prepared according to the 
method of Seglen [16] using collagenase. Viability of 
hepatocytes used was above 90% (estimated by trypan 
blue exclusion test). GSH depletion in hepatocytes was 
achieved by incubating the cells (2 X 10 6 cells/ml) in 
Hepatocytes loaded with GSH (GSH-hepatocytes) was 
prepared as follows: hepatocytes (2 X 10 6 cells/ml) were 
incubated in HBBS containing various concentrations of
GSH at 37°C for the specified times. The amount of GSH 
transported into hepatocytes was estimated from the in- 
crease of intracellular GSH content by incubation. GSH 
was measured by the above-described nzymatic recycling 
method. 
2.6. Estimation of y-GCE taken up into hepatocytes pre- 
treated with and without BNPP and its conversion to GSH 
within the cells 
Hepatocytes loaded with ~/-GCE (~-GCE-hepatocytes) 
was prepared as follows: hepatocytes (2 X 10 6 cells/ml) 
were incubated in HBBS containing various concentrations 
of ~/-GCE at 37°C for the specified times. Inhibition of 
intracellular esterase activity by treatment with BNPP, a 
non-specific esterase inhibitor [20,21] was conducted in 
hepatocytes as follows: hepatocytes (2 X 10 6 cells/ml) 
were incubated in HBSS containing 250 ixM BNPP for 10 
min at 37°C before incubation with ,/-GCE as described by 
Carini et al. [22]. Esterase activity in the cells was deter- 
mined by the method of Li et al. [23]. The amount of 
~/-GCE transported into hepatocytes was roughly estimated 
from the increase of intracellular nonprotein-SH (NP-SH) 
content by incubation. The amount of GSH derived from 
",/-GCE in hepatocytes was estimated from the increase of 
intracellular GSH content by incubation. Both ",/-GCE 
transport into hepatocytes and its conversion to GSH within 
the cells were further estimated by checking the contents 
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Fig. 1. Effect of DEM treatmen~L onintracellular GSH concentration in 
hepatocytes and LDH release from the cells into the medium. Isolated 
hepatocytes (2X 10 6 cells/ml) in HBSS were incubated with 1.0 mM 
DEM at 37°C for the indicated times. The concentration f GSH (closed 
circle) in DEM-treated hepatocytes and the activity of LDH (open square) 
released from the cells into the raedium were determined asdescribed in
Section 2. For intracellular GSH concentration, GSH concentration in 
fresh, DEM-untreated hepatocytes was taken as 100%. Each point is a 
mean 5: S.D. from three independent experiments. 
C18 5-~m column (4.6 x 250 mm) (Gasukuro Kogyo Co., 
Tokyo, Japan) and a flow rate of 1 ml /min  were used. 
Elution was performed with solvent A and B; solvent A 
was a mixture of 2.5% (v /v )  acetic acid adjusted to pH 
3.5 and 50% (w/v )  NaOH and solvent B a mixture of 
solvent A and acetonitrile (1:1 v/v) .  
2.7. Statistical analysis 
Results obtained are expressed as means +__ S.D. Results 
are analyzed by computerized statistical packages (Super- 
ANOVA, Statview II) if necessary. Each mean value is 
compared by one-way analysis of variance and Fisher's 
protected least significant difference for multiple compar- 
isons as the post hoc test. The level of significance was 
taken as P < 0.05. 
3. Results 
of ~/-GCE and its related compounds uch as GSH, ~/-GC, 
CysOEt, and Cys in hepatocytes. ~/-GCE-heaptocytes with 
and without BNPP pretreatment were homogenized in 10 
vol of ice-cold 2.5% sulfosalicylic acid. NP-SH in the 
supernatant of the homogenate, obtained by centrifugation 
(10000 x g, l0 min) at 4°C, was measured by the DTNB 
method of Sedlak and Lindsay [24]. In this DTNB method, 
"y-GCE, GSH, ",/-GC, CysOEt, and Cys were determined in 
the same sensitivity. Although GSH was determined by the 
above-described nzymatic recycling method, ",/-GCE and 
its related compounds such as ~/-GC, CysOEt, and Cys had 
no significant effect on the determination. For the simulta- 
neous measurements of ~-GCE, GSH, ~/-GC, CysOEt, and 
Cys in ~/-GCE-hepatocytes, free thiols in the supernatant 
were converted to their fluorescent derivatives by reaction 
with MB. The preparation of the derivatives and their 
determinations were carded out according to the method of 
Newton et al. [25] with some modifications. The deriva- 
tives were separated and measured at room temperature 
using a Shimadzu LC-4A gradient liquid chromatograph 
(Shimadzu Co., Kyoto, Japan) equipped with a JASCO 
FP770 spectrophotometer with a micro flow cell MFC-130 
(JASCO Co., Hachioji, Japan) and a Shimadzu C-R3A 
integrator (Shimadzu Co,  Kyoto, Japan). An Inertsil ODS- 
3.1. Effect of  DEM treatment on intracellular GSH concen- 
tration in hepatocytes and LDH release from the cells 
When isolated rat hepatocytes were treated with 1.0 
mM DEM, intracellular GSH concentration decreased by 
23% of the original concentration 5 min after DEM treat- 
ment and the decreased level was unchanged thereafter 
(Fig. 1). There was no increase in LDH released from the 
DEM-treated hepatocytes into the medium during the incu- 
bation period, indicating that there was no effect of GSH 
depletion by DEM treatment on the cell viability. 
3.2. GSH synthetic activity in hepatocytes 
GSH synthetic activity in hepatocytes was checked by 
the increase of GSH concentration when the cells were 
incubated in the medium containing Glu, Gly, Met, and 
Ser. As shown in Table 1, hepatocytes incubated with 
GSH precursors, which were the above-described amino 
acids, showed a 7.4-fold increase in GSH concentration as 
compared with hepatocytes incubated without GSH precur- 
sors for the same time. In addition, this value obtained was 
equivalent to 86% of that of fresh hepatocytes without any 
treatment, indicating that the hepatocytes possessed a nor- 
Table 1 
GSH synthetic activity in hepatocytes using L-glycine, L-glutamic acid, L-serine, and L-methionine 
Hepatocytes GSH (nmol/2 x 106 cells) % of control 
Fresh hepatocytes without any treatment (control) 42.3 4- 9.3 100 
Hepatocytes without GSH precursors 4.9 4- 3.2 12 
Hepatocytes with GSH precursors 36.4 4- 6.0 * 86 
Hepatocytes were incubated with and without 1.0 mM L-glutamic acid, 1.0 mM L-serine, and 1.0 mM L-methionine at37°C for 30 min. GSH synthetic 
activity was estimated from tile increase of intracellular GSH concentration by incubation with GSH precursors. GSH concentration in hepatocytes was 
determined asdescribed in Section 2. Each value is a mean + S.D. from independent five experiments. * P < 0.001 (vs. hepatocytes without GSH 
precursors). 
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mal GSH synthetic activity. Therefore, GSH-depleted hep- 
atocytes prepared under the above-mentioned conditions 
were used in all experiments described below. 
3.3. Time-course of NP-SH concentrations in y-GCE- 
hepatocytes 
As shown in Fig. 2A, NP-SH concentration i  unloaded 
hepatocytes was reduced to about half of the original evel 
at 10-min incubation and this decreased NP-SH concentra- 
tion was unchanged thereafter. NP-SH concentration i
"y-GCE (0.1 and 5.0 mM)-hepatocytes increased almost 
linearly with the incubation time. 
3.4. Time-course of GSH concentration in T-GCE- or 
GSH-hepatocytes 
Changes of GSH concentration i  ",/-GCE (0.1 and 5.0 
mM)- or GSH (0.1 and 5.0 mM)-hepatocytes, and un- 
loaded hepatocytes are shown in Fig. 2B. GSH concentra- 
tion in unloaded hepatocytes was reduced to about half of 
the original level at 10-min incubation and this decreased 
GSH level was unchanged thereafter. GSH concentration 
in ~/-GCE (0.1 and 5.0 mM)-hepatocytes increased almost 
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Fig. 2. Time courses of NP-SH concentration i "y-GCE-hepatocytes (A) 
and of GSH concentration i 3,-GCE- or GSH-hepatocytes (B). Hepato- 
cytes (2× 106 cells/ml) were incubated in HBSS containing 0.1 mM 
(open triangle) or 5.0 mM (closed triangle) ~/-GCE, or 0.1 mM (open 
circle) or 5.0 mM (closed circle) GSH at 37°C for indicated times. 
Hepatocytes (2X 106 cells/ml) used the control (open square) were 
incubated in HBSS alone for the same period. NP-SH and GSH concen- 
trations in these hepatocytes were measured as described in Section 2. 
Each point is a mean 5: S.D. from five independent experiments. 
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Fig. 3. Effect of ~/-GCE on GSH and NP-SH concentrations in hepato- 
cytes as a function of concentration. Hepatocytes (2× 106 cells/ml) were 
incubated with or without indicated concentrations of ~/-GCE at 37°C for 
I0 min. NP-SH (open circle) and GSH (closed circle) concentrations in 
these hepatocytes were measured as described in Section 2. Each point is 
a mean + S.D. from five independent experiments. 
linearly with the incubation time. GSH concentration i
GSH (0.1 mM)-hepatocytes changed in a manner similar to 
the case of unloaded hepatocytes. In GSH (5.0 mM)- 
hepatocytes, an increase in GSH concentration ccurred in 
a manner similar to the case of ~/-GCE (5.0 mM)-hepato- 
cytes for the first 10 min. However, this increase stopped 
after 20-min incubation. At 30-min incubation, GSH con- 
centrations in ~/-GCE (5.0 mM)- and GSH (5.0 mM)- 
hepatocytes were equivalent to 83% and 57% of that in 
fresh hepatocytes without DEM treatment, respectively. 
Thus, the ability of ~/-GCE to increase hepatocellular GSH 
levels was much higher than that of GSH itself. 
3.5. Dose-dependency of T-GCE on its increasing effect on 
GSH concentration i hepatocytes 
GSH concentration i  ~/-GCE (0.1 to 5.0 mM)-hepato- 
cytes increased in parallel with an increase in NP-SH 
concentration (Fig. 3). However, this loading of ",/-GCE at 
more than 0.5 mM caused gradual increases in hepato- 
cellular GSH and NP-SH concentrations. 
3.6. Concentrations of fee thiols in y-GCE-hepatocytes 
with and without BNPP pretreatment 
When fresh hepatocytes were incubated in HBSS with 
and without 250 I~M BNPP, esterase activity in the 
BNPP-treated cells was 6.2 + 0.1 U/2  × 106 cells (n = 5), 
while that activity in the BNPP-untreated cells was 23.1 + 
3.3 U /2  × 10 6 cells (n = 5). Hence, the concentrations of 
free thiols such as ~/-GCE, ~/-GC, CysOEt, GSH, and Cys 
in ~/-GCE (5.0 mM)-hepatocytes with and without BNPP 
pretreatment were determined in order to confirm the 
-,/-GCE conversion to GSH after its hydrolysis to ~/-GC via 
esterase within the hepatocytes. As shown in Fig. 4, not 
only GSH and Cys but also ",/-GCE, -,/-GC, and CysOEt 
existed in the ~/-GCE-hepatocytes with and without BNPP 
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Fig. 4. Effect of "y-GCE on the concentrations f free thiols in hepato- 
cytes with and without BNPP pretreatment. Hepatocytes (2×106 
cells/ml) were preincubated with (closed bar) and without (open bar) 250 
~M BNPP in HBSS at 37°C for 10 rain. The hepatocytes preincubated 
with and without BNPP were incubated with 5.0 mM ~/-GCE for 30 rain, 
and then concentrations f "y-GCE, -/-GC, GSH, CysOEt, and Cys in the 
hepatocytes were determined using high-performance liquid chromatog- 
raphy as described in Section 2. Each point is a mean + S.D. from five 
independent experiments. *, P < 0.01; * *, P < 0.001 (vs. hepatocytes 
without BNPP pretreatment). 
pretreatment. The concentrations of GSH and ",/-GC in the 
v-GCE-hepatocytes with BNPP pretreatment were 40 and 
60%, respectively, of those in the ~-GCE-hepatocytes 
without BNPP pretreatment. In contrast, the concentrations 
of ",/-GCE and CysOEt iin the -,/-GCE-hepatocytes with 
BNPP pretreatment were 8.1- and 2.3-fold higher than 
those in the ~/-GCE-hepa.tocytes without BNPP pretreat- 
merit, respectively. However, ~/-GCE loading had no effect 
on the concentration of Cys and the total amount of 
"v-GCE, ~/-GC, CysOEt, Cys, and GSH in the hepatocytes 
with and without BNPP pretreatment. 
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Fig. 5. Lineweaver-Burk plot of kinetics of ~/-GCE uptake into hepato- 
cytes. ~/-GCE uptake into hepatocytes (2× 106 cells/ml) was assayed at 
substrate concentrations of 0.5 to 10.0 mM in HBSS for 2 rain as 
described in Section 2. The rate is expressed as nmol NP-SH 
increased/min per 2 × 106 cells. Each point is the mean of three indepen- 
dent experiments. 
3.7. Mode of 7-GCE transport into hepatocytes 
The activity of ~-GCE transport into hepatocytes was 
estimated from the increase of NP-SH concentration i the 
-,/-GCE-hepatocytes, loaded 0.5, 1.0, 2.5, 5.0, and 10.0 
mM for 2 min. A double-reciprocal plot for the activity 
and the concentration of the SH-compound, i.e., 
Lineweaver-Burk plot, was depicted as shown in Fig. 5. 
This plot yielded one linear curve with a zero intercept, 
indicating the occurrence of ",/-GCE transport into hepato- 
cytes in a diffusion manner. 
4. D iscuss ion  
The present study has clearly shown the conversion of 
",/-GCE to GSH in liver cells. This finding was confirmed 
using GSH-depleted rat hepatocytes without cell damage 
which were prepared by treatment with DEM, a GSH 
depletor (Fig. 1). The activity of GSH synthesis via ~/-Glu- 
Cys synthetase and GSH synthetase in the DEM-treated 
hepatocytes was found to be maintained almost at the level 
of fresh hepatocytes without DEM treatment when deter- 
mined using Glu, Gly, Ser, and Met in which Cys was 
produced from Met and Ser via the transsulfuration path- 
way in the hepatocytes [26] (Table 1). 
The intracellular conversion of ~/-GCE to GSH was 
examined using GSH-depleted hepatocytes with and with- 
out pretreatment of BNPP, which is known to be an 
inhibitor of non-specific esterase [20,21], by checking the 
changes of intracellular GSH, ~/-GCE, "y-GE, CysOEt, and 
Cys concentrations following ~-GCE loading (Fig. 4). It 
has been shown that esterase is present in the cytoplasm of 
liver cells [27,28]. Esterase activity in hepatocytes with 
BNPP pretreatment was much lower than that in hepato- 
cytes without BNPP pretreatment. When 5.0 mM ~/-GCE 
was loaded to hepatocytes with and without BNPP pre- 
treatment for 30 min, "y-GCE-hepatocytes with BNPP pre- 
treatment had a significantly larger amount of ~-GCE than 
~/-GCE-hepatocytes without BNPP treatment. In contrast, 
the former cells possessed a significantly lower amount of 
GSH than the latter cells. However, there was no differ- 
ence in the total amount of ",/-GCE and its related com- 
pounds such as GSH, ~/-GC, CysOEt, and Cys between 
both ~/-GCE-hepatocytes. We have also observed an in- 
crease in intracelular GSH concentration i  cultured mouse 
hepatocytes pretreated with DL-buthionine sulfoximine, a 
",/-glutamylcysteine synthetase inhibitor, by ",/-GCE loading 
(unpublished ata). This observation supports that conver- 
sion of ~/-GCE within hepatocytes occurs via glutathione 
synthetase, but not ~-glutamylcysteine synthetase. Accord- 
ingly, these findings indicate that ~-GCE taken up by liver 
cells is converted to GSH via glutathione synthetase after 
its hydrolysis to ",/-GC, a substrate for glutathione syn- 
thetase, and ethanol by esterase present in the cells. 
Furthermore, when ~/-GCE was loaded to GSH-depleted 
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hepatocytes, a small amount of CysOEt was produced in 
the cells. This result suggests the possibility that a small 
part of 3~-GCE taken up by liver cells is metabolized to 
CysOEt by ~/-glutamyltranspeptidase present in the plasma 
membrane. 
When ~/-GCE was loaded to GSH-depleted hepatocytes, 
NP-SH concentration i  the cells was found to increase 
almost linearly with incubation time (Fig. 2A). This result 
suggests that ~-GCE is taken up into hepatocytes almost in 
a time-dependent manner. The increases of NP-SH and 
GSH concentrations in "7-GCE-hepatocytes showed dose- 
independent manner when the concentration of ~/-GCE 
loaded was more than 0.5 mM (Fig. 3). When ",/-GCE was 
loaded to fresh hepatocytes without GSH depletion by 
DEM-pretreatment, a marked enhancement of NP-SH con- 
centration did not occur in the cells (data not shown). 
Presumably, the uptake of "7-GCE into hepatocytes de- 
pends upon intracellular GSH level. 
",/-GCE is a zwitten ion that can be considered to be an 
analogue of oL-amino acids. It has been demonstrated that 
a-amino acids are taken up into hepatocytes via a carrier- 
mediated mechanism, i.e., via a saturable transport process 
[29-31]. The analysis of the mode of transport of each 
a-amino acid into hepatocytes i often carried out using 
the Lineweaver-Burk plot. In the case of a-amino acids, a 
linear curve with a non-zero intercept is depicted. When 
the mode of ~/-GCE uptake into hepatocytes was analyzed 
using the Lineweaver-Burk plot, however, a linear curve 
with a zero intercept was depicted (Fig. 4). This result 
indicates that unlike e~-amino acids, "7-GCE is taken up 
into hepatocytes in a diffusion manner, but not via a 
carrier-mediated mechanism. In the present study, the in- 
crease of intracellular GSH concentration was observed 
when 5.0 mM GSH was loaded to GSH-depleted hepato- 
cytes, but not when 0.1 mM GSH was loaded (Fig. 2B). 
Namely, GSH uptake into GSH-depleted hepatocytes oc- 
curred only when its concentration used was much higher 
than its physiological extracellular concentration (ca. 50 
IxM). Carcia-Ruiz et al. [6] have reported similar results 
that extracellular GSH in much higher concentrations than 
its physiological concentration stimulates GSH influx into 
GSH-depleted rat hepatocytes, while its physiological con- 
centration causes GSH efflux. Recently, Yi et al. [32] have 
shown the existence of GSH transporter responsible for the 
uptake of extracellular GSH in a high concentration by rat 
hepatocytes. Accordingly, it can be thought hat GSH is 
taken up into hepatocytes via a carrier-mediated mecha- 
nism similar to the case of a-amino acids. From these 
findings, it is suggested that there is a difference in 
hepatocellular t ansport mechanism between GSH and "7- 
GCE. 
In conclusion, the results obtained in the present study 
allow us to depict the schema for the uptake of ~/-GCE 
into liver cells and its conversion to GSH within the cells 
as shown in Fig. 6. The results obtained here also allow us 
to think that the increase of hepatic GSH levels in new-born 
mice injected with "7-GCE [12] and the maintenance of 
hepatic GSH levels by ~/-GCE treatment in rats with 
ischemia/reperfusion-induced liver injury [13,14] are due 
to the transport of this SH-compound into the liver and its 
conversion to GSH via esterase and glutathione synthetase 
within the tissue. This transport of "7-GCE into liver cells 
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Fig. 6. Schematic representation f the conversion of ~-GCE to GSH in hepatocytes. ~,-Glu-Cys ynthetase, ~t-glutamylcysteine synthetase; GSH 
synthetase, glutathione synthetase; 3,-GTP, ~/-glutamyltranspeptidase. 
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and its conversion to GSH within the cells also seems to 
account for the maintenance of  intracellular GSH levels 
found in immunological ly  injured rat hepatocytes with 
~/-GCE-treatment [15]. Although we have demonstrated the 
conversion from ~/-GCE to GSH in hepatocytes, further 
study is necessary to clarify the mechanism for the trans- 
port of this compound into hepatocytes. 
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